RELMADA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.53 USD | 0.00% |
|
-8.31% | -14.73% |
| 05-08 | Transcript : Relmada Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
| 05-08 | Relmada Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RELMADA THERAPEUTICS, INC. | Bio Therapeutic Drugs | 0.00% | -8.31% | -14.73% | +14.24% | -49.57% | 107M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RLMD Stock
- Charts Relmada Therapeutics, Inc.
- Comparison Chart
